Clinical study of comparing LP and TP regimens in the treatment of advanced non-small cell lung cancer
Jianfei Gao(Shenyang Pharmaceutical University), Bicheng Zhang(University of Electronic Science and Technology of China), Wenjuan Deng(Wuhan General Hospital of Guangzhou), Sha Guan, Zhiguo Rao(Lanzhou University), Guo-chao Qiu(Wuhan General Hospital of Guangzhou)
Cited by 4
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256
Clinical characteristics of 82 death cases with COVID-19
|medRxiv|2020|249